LB Form 4: Director Daul Ty P. receives 3,895 RSUs under LTIP
Rhea-AI Filing Summary
Daul Ty P., a director of LandBridge Company LLC (LB), received a grant of 3,895 restricted stock units (RSUs) on 08/27/2025 under the company's Long-Term Incentive Plan. The RSUs were granted with a $0 price and vest on July 1, 2026, generally conditioned on continued service on the board through that date. Following the grant, the reporting person beneficially owns 20,048 Class A shares. The Form 4 was signed on 08/28/2025 by an attorney-in-fact, Scott L. McNeely.
Positive
- Grant aligns director incentives via time‑based RSUs that vest contingent on continued service
- Clear disclosure of transaction date, grant amount (3,895 RSUs), vesting date (07/01/2026), and post‑grant beneficial ownership (20,048 shares)
Negative
- No performance‑based vesting disclosed; vesting appears solely service‑based
- Price $0 indicates compensation expense rather than personal investment by the director
Insights
TL;DR: Director received time‑based RSUs that align compensation with continued board service.
The filing documents a routine, time‑based equity grant of 3,895 RSUs to a director under the Long‑Term Incentive Plan, vesting July 1, 2026, subject to continued board service. Such grants are commonly used to align director incentives with shareholder interests and retain independent directors. The $0 price indicates these are compensation awards rather than open‑market purchases. The post‑grant beneficial ownership of 20,048 Class A shares provides the director with ongoing equity exposure, but the information contains no performance conditions or accelerated vesting terms.
TL;DR: Transaction appears compliant with Section 16 reporting; disclosure is specific and routine.
The Form 4 discloses the transaction date (08/27/2025), grant amount (3,895 RSUs), and vesting date (07/01/2026), fulfilling standard Section 16 reporting elements. The signature by an attorney‑in‑fact is provided with a filing date of 08/28/2025. There are no derivative transactions reported and no indication of Rule 10b5‑1 or other trading plans. From a compliance perspective, the filing contains the expected factual elements without apparent omissions.